APA (7th ed.) Citation

Li, Y., Cao, Y., Wang, X., Li, C., Zhao, L., & Li, H. Effects of perioperative treatment of resectable adenocarcinoma of esophagogastric junction by immunotherapy (Adebrelimab) combined with chemotherapy (XELOX): Protocol for a single-center, open-labeled study (AEGIS trial, neoadjuvant immunochemotherapy). BMC.

Chicago Style (17th ed.) Citation

Li, Yingyi, Yuqin Cao, Xipeng Wang, Chengqiang Li, Liqin Zhao, and Hecheng Li. Effects of Perioperative Treatment of Resectable Adenocarcinoma of Esophagogastric Junction by Immunotherapy (Adebrelimab) Combined with Chemotherapy (XELOX): Protocol for a Single-center, Open-labeled Study (AEGIS Trial, Neoadjuvant Immunochemotherapy). BMC.

MLA (9th ed.) Citation

Li, Yingyi, et al. Effects of Perioperative Treatment of Resectable Adenocarcinoma of Esophagogastric Junction by Immunotherapy (Adebrelimab) Combined with Chemotherapy (XELOX): Protocol for a Single-center, Open-labeled Study (AEGIS Trial, Neoadjuvant Immunochemotherapy). BMC.